Acute systemic fetal inflammation in a sheep model of early pregnancy is not driven by cells in the fetal blood.
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INTRODUCTION
Preterm birth (PTB; delivery before 37 weeks' completed gestation) is a multi-origin syndrome 1 that results in excess of 1 million perinatal deaths each year 2, 3 . The preterm deliveries at highest risk of death and significant disability are those occurring at or below 32 weeks of gestation, most commonly in association with intrauterine infection 4 and chorioamnionitis 5 . Goldenberg and colleagues have suggested that between 25 and 40% of preterm births are due to infection, noting that the true rate may in fact be higher due to spuriously negative microbial culture results 6 . An increased risk of adverse neonatal outcomes is also independently associated with an elevated cord blood plasma interleukin (IL)-6 level (>11pg/mL), termed the fetal inflammatory response syndrome or FIRS 7 .
In the presence of microbial agonist, innate immune receptors (including the TOLL-, NOD-, and RIG-I-like receptor families) in fetal and maternal tissues drive the expression and release of pro-inflammatory mediators including IL-1α/β, IL-6, IL-8 and tumour necrosis factor (TNF)-α 1, 4, 8 . Intrauterine inflammation is considered key to both the premature activation of the pathways of parturition and a number of the diseases (e.g. cerebral palsy) associated with prematurity 8, 9 . As such, interventions that resolve both intrauterine infection and inflammation may prevent microbially-associated PTB and its sequelae. A number of investigators have studied responses to intrauterine infection and inflammation in primate 10, 11 , sheep 12, 13 , and rodent models 14, 15 of pregnancy. However, much remains to be understood with regards the tissues responsible for driving intrauterine inflammation. Of note, a significant number of previous studies in this field have been undertaken in lategestation pregnancies 4 .
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We aimed to chronically catheterise fetal sheep to characterise the acute intrauterine inflammatory response to E.coli lipopolysaccharide (LPS) in very preterm fetuses. Noting that LPS does not cross cell-cell barriers 16 , we hypothesised that any acute fetal systemic inflammatory responses would be driven by signalling from the tissues exposed to the amniotic fluid (AF).
MATERIALS AND METHODS
Animals: Animal studies were approved by The University of Western Australia's Animal
Ethics Committee (approval RA/3/100/1289). 18 date-mated ewes with singleton fetuses at 92d gestational age (GA) had aseptic recovery surgery to place catheters into the fetal jugular vein, trachea and two catheters into the AF as described previously 17 . After a 24h recovery, animals were assigned at random to receive either: i) 10mg E.coli LPS (O55:B5;
Sigma Aldrich, St. Loius, MO) in 2mL sterile saline via intraamniotic catheter (n=9); or ii) 2mL sterile saline via intraamniotic catheter (n=9).
Amniotic fluid (AF), tracheal fluid (TF) and fetal plasma (FP) were serially sampled immediately before and 2, 4, 8, 12, 24 and 48h after treatment administration. Animals were euthanised with an intravenous bolus (100mg/kg) of pentobarbitone at 48h. Fetal cord blood was collected for blood chemistry analysis, and for RNA extraction using PAXgene Blood RNA Tubes (PreAnalytiX GmbH, Switzerland) in accordance with manufacturer's instructions. Fetal tissues were snap frozen in liquid nitrogen for subsequent analysis. 6-9
animals were analysed per group.
Tissue RNA preparation: RNA was isolated from fetal tissues (internal groin skin, spleen, lung right lower lobe, frontal cortex), and mechanically disrupted with a Precellys homogeniser M A N U S C R I P T A C C E P T E D Affymetrix, Santa Clara, CA) was performed on arterial cord blood RNA collected at necroscopy from 4 LPS-exposed and 4 saline-exposed fetuses selected at random. All RNA samples underwent quality control assessment for purity and integrity and had a RIN value of between 6.5 and 8.8. For each sample, 100 ng of total RNA was processed using a WTPlus assessed for normality. Mean differences between normally distributed data were tested for significance with one-way ANOVA using a p value of 0.05. Tukey's test was used to perform multiple post-hoc comparisons. Between-group differences in non-parametric data were tested for significance with Kruskal-Wallis one-way ANOVA, with a p value of 0.05 accepted as significant. Rank-sum tests were used to perform multiple post-hoc comparisons were performed with the p value corrected for n multiple comparisons where appropriate.
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RESULTS
Clinical observations: All surgeries were successfully completed and there were no fetal deaths prior to scheduled euthanasia. No significant differences were identified in birth weight, arterial cord blood pH, pO 2 , pCO 2, lactate, glucose or white blood cell counts (total or differential) between treatment and control groups. None of the study animals had meconium and there was no increase in the presence of fetal edema or ascites as a result of LPS exposure. Compared to Saline Control, the concentration of γ-glutamyltransferase (a marker of oxidative stress) in fetal cord blood plasma collected at euthanasia was significantly increased (p<0.05) at necroscopy in animals exposed to LPS for 48h (Table 1) .
Endotoxin quantification: For animals randomised to LPS-exposure, the endotoxin levels in both AF and TF were below the assay limit of detection (0.1EU/mL) immediately before LPS administration. Endotoxin concentrations in the AF and TF exceeded 1EU/mL by 2h and remained above 1EU/mL at all subsequent time points to 48h.
ELISA: All values are median (25 th -75 th centile). Statistical comparisons are relative to saline control samples collected contemporaneously at matched time points. There were no significant increases in TNF-α concentrations in AF, TF or FP at any time point (data not shown). IL-6 concentrations were significantly increased in AF from LPS-exposed fetuses at 12h, 24h, and 48h, relative to Saline Controls. IL-6 concentrations were significantly increased in TF from LPS-exposed fetuses at 24h, and 48h, relative to Saline Control. IL-6
concentrations were significantly increased in FP from LPS-exposed fetuses at 12h, relative to Saline Control (Table 2) .
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13 IL-8 concentrations were significantly increased in AF from LPS-exposed fetuses at 4h, 8h, 12h, 24h, and 48h, relative to Saline Control. IL-8 concentrations were significantly increased in TF from LPS-exposed fetuses at 2h, 4h, 12h, 24h, and 48h, relative to Saline
Control. IL-8 concentration was significantly increased in FP from LPS-exposed fetuses at 12h, relative to Saline Control (Table 3) .
MCP-1 concentrations were significantly increased in AF from LPS-exposed fetuses at 4h, 8h, 12h, 24h, and 48h, relative to Saline Control. MCP-1 concentrations were significantly increased in TF from LPS-exposed fetuses at 8h, 12h, 24h, and 48h, relative to Saline
Control. MCP-1 concentrations were significantly increased in FP from LPS-exposed fetuses at 4h, 8h, 12h, 24h, and 48h , relative to Saline Control (Table 4) . There was no change in cytokine / chemokine expression in fetal cortex tissue ( Figure 1B ; IL-6, IL-8, MCP-2, IL-13) or RNA collected from fetal arterial cord blood ( Figure 1E ; IL-1β, IL-8, TNF-α; IL-6 and MCP-2 were not detectable in either control or LPS-exposed groups).
Microarray: Using a SAM analysis with a false discovery rate of 0.1, 63 genes were found to be significantly differentially expressed between LPS-and saline-exposed groups. Array data CDKN2A encodes the tumour-suppressor protein p16, which exerts a negative influence on cell cycling by preventing the transition from G1 phase to S phase 23 .
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COMMENT
The present work describes the successful development of a chronically catheterized sheep model to study inflammatory responses generated by very preterm fetuses. This study presents three key findings pertinent to advancing our understanding of the inflammatory pathophysiology that underpins the fetal inflammatory response syndrome in very preterm fetuses:
i) when administered to the AF, LPS rapidly (within 2h of administration) entered the TF. We, and others, have previously shown the fetal lung to be a key organ in driving systemic fetal inflammatory responses 12 . These data similarly suggest that microorganisms gaining access to the intrauterine environment (i.e. by ascending An absence of cytokine/chemokine RNA expression changes in whole arterial blood collected at euthanasia, very modest changes in spleen cytokine mRNA expression, and limited changes in markers of liver inflammation, oxidative stressand injury (AST, γGT, GLDH) together suggest that the acute systemic fetal inflammatory response to LPS is driven by fetal tissues exposed to the amniotic environment.
Given the importance of inflammation to preterm labour and fetal injury, there is significant interest in developing and testing anti-inflammatory interventions to complement antibiotic therapies in the setting of infection-associated preterm birth. To date, investigators have used a variety of pharmacological approaches in an attempt to regulate intrauterine inflammation 13, [25] [26] [27] .
We characterised the acute fetal responses to intraamniotic endotoxin exposure in chronically catheterized fetal sheep at 62% of gestation to model early gestational inflammatory responses. These data are of importance for the development of interventions to identify and target the tissues that respond to intrauterine inflammatory stimulation. Moreover, because fetal immunological capacity is a function of gestational development 4, 28 , the use of gestation-appropriate fetuses is an important consideration in M A N U S C R I P T
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18 infection-associated PTB model system selection. We and others have previously investigated fetal lung responses to LPS fetuses at approximately 80% of gestation 29 . In the present study, we demonstrate that the very preterm fetal lung also has the capacity to mount a robust pro-inflammatory response to microbial agonist. The fetal skin has also been suggested as a potential pro-inflammatory organ in humans 30 and we have previously characterised its responses to LPS 31 , and preterm birth associated organisms such as
Ureaplasma parvum 32 and Candida albicans 19 in mature fetuses. In the present study, LPS exposure yielded modest increases in fetal skin cytokine mRNA expression, notably IL-8, in keeping with earlier reports. These data reinforce the ability of the fetus to mount a robust pro-inflammatory response to microbial agonist from an early GA. From a model perspective, significant increases in FP IL-6, and an IL-6 driven signalling response in fetal cord blood cells reinforces the utility of the sheep as a model system for intrauterine infection in human pregnancy 33 .
From a treatment-development perspective, two of study findings are of particular relevance. Firstly, the speed at which inflammatory changes became detectable in the TF, AF and FP following LPS administration is of great interest. The hypothetical therapeutic window for administering anti-inflammatory therapies to the fetus to prevent preterm labour and brain/lung injury remains unknown, but is likely dependent on the infecting organism and host susceptibility. Previous studies have demonstrated neurological injury in association with intrauterine inflammation 34 . The present study was not designed to assess neurological injury, although it is interesting to note an absence of inflammatory changes in a limited panel of mediators measured in the fetal cortex at 48h. Developing antiinflammatory therapies for PTB prevention is likely an important element of our quest to M A N U S C R I P T
19 prevent PTB and improve perinatal outcomes. However, the speed with which (<2h) the fetus responded to agonist in the present study, along with previous work demonstrating pathological changes in the fetal brain following exposure to even sub-clinical doses of LPS 35 , serve to highlight the urgent need for better tests to identify women at risk of intrauterine infection and PTB.
Secondly, and of particular interest, is the nature of the response presumably mounted by circulating immunocytes to acute fetal inflammation. Surprisingly, this response was characterised by inhibition of cell-cycle control, proliferation, but an absence of de novo inflammatory mediator expression. In keeping with previous animal studies, quantitative or qualitative changes in immunocyte populations were not detected after 48h of LPS exposure in this study. It is, however, tempting to speculate that the pro-proliferative signalling state identified in the present study is in keeping with qualitative and quantitative changes in immunocyte populations previously identified in LPS-exposed sheep fetuses by 7d 29 .
Appropriate targeting of anti-inflammatory therapies is an important consideration as immunocyte proliferation and differentiation plays a crucial role in augmenting the host response to infection. Ureaplasma spp. are the microorganisms most commonly isolated from cases of early PTB; data from clinical studies suggest that perhaps up to 30% of very early preterm infants are cord-blood culture positive for Ureaplasma spp [36] [37] [38] [39] . In these cases, the presence of systemic microbial agonist argues for the need for anti-inflammatory agents to reach the fetal circulation. However, it appears that in the majority of cases, infection (and thus pro-inflammatory agonist) is restricted to the AF. In these cases, risking systemic fetal immune-modulation may be unnecessary, especially if it were to inhibit immunocyte proliferation, which is crucial in allowing the fetus to protect itself from microbial invasion.
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There are a number of factors to consider when interpreting the data presented above.
Sheep provide a well-validated model with which to study fetal inflammatory responses to microbial agonist; however it is important to note that unlike a number of species (including rodents and non-human primates), administration of LPS in early-mid pregnancy does not induce the onset of labour 31 . Secondly, there are well documented differences between species with regards to sensitivity to LPS 40 , and it is possible that a more vigorous fetal response, or analysis outside of the 48h window used in this study, may both lead to the identification of de novo cytokine/chemokine production by cells in the blood. Lastly, the present study models fetal responses to microbial agonist (LPS) in the AF. It would be of particular interest to determine the effect of alternative models of infection, such as acute trophoblast infection (with and without AF involvement) on fetal inflammatory responses.
CONCLUSIONS
Developing interventions to control the pathological inflammation associated with intrauterine infection is likely an important step in our efforts to prevent PTB and fetal injury. The availability of gestation-appropriate animal models, such as that described in the present study, will likely play a critical role in this work. In successfully developing a chronically catheterized sheep model of early pregnancy, our data demonstrate that the very premature fetus rapidly generates a robust inflammatory response in response to intraamniotic LPS exposure. In the absence of bacteraemia, acute systemic inflammation appears to be driven by amniotic-fluid exposed tissues; fetal blood cells (presumably immunocytes) respond to systemic inflammation by entering a pro-proliferative state but do not contribute to the acute production of inflammatory mediators.
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This study advances our understanding of fetal responses to microbial agonist at a gestational age which is frequently associated with very early preterm birth. This study underscores the need to appropriately target anti-inflammatory therapies to fetal tissues exposed to the agonist-containing AF, and highlights the likely importance of the fetal lung.
The speed at which substantial intrauterine inflammation occurs and the comparatively subtle nature of acute fetal systemic inflammatory responses also reinforces the urgent need to seek improved means of identifying women at risk of intrauterine infection. 
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